View the HPLC Certificate here
This study includes COVID-19 and COVID-like illness, with 49% of 128 patients receiving a PCR test being COVID-1
By analyzing the aortic tissue, we found that FOXO4-DRI treatment significantly increased the expression levels of Ki-67 and Lamin B, while reducing the expression of P21, P16, and -H2AX, similar to the results obtained from naturally aged mice (Figure 2A)
The following documents should accompany every research peptide import from non-EU countries: Commercial invoice (Handelsrechnung): Must include sender/receiver details, item descriptions with chemical names, HS tariff codes, quantities, declared values in EUR, and Incoterms Packing list: Detailed contents of each package, including lot numbers and quantities per peptide Certificate of Analysis (COA): Batch-specific HPLC purity data, mass spectrometry confirmation, and identity testing results from the vendor or third-party laboratory End-use declaration (Endverbleibserklrung): Statement confirming research-only use, signed by the importing institution's authorized representative Laboratory registration proof: Copy of Gewerbeanmeldung (business registration) or university department letterhead confirming research facility status Safety Data Sheets (SDS/Sicherheitsdatenbltter): Required for each peptide in the shipment under EU REACH regulation EORI number: Your Economic Operators Registration and Identification number, mandatory for all EU customs declarations For intra-EU shipments from vendors like Europeptides, Beyond Peptides, or Primal Peptides, the documentation requirements are significantly reduced
